Clinical Applications Beyond the Gut: Expanding Microbiome Therapeutic Horizons
The Human Microbiome Based Drugs Diagnostics Market is rapidly expanding beyond its gastrointestinal origins into diverse therapeutic areas that leverage the systemic influence of microbial communities on human physiology. While approximately 70% of current microbiome therapeutics target gastrointestinal disorders and 20% focus on immunology and oncology, emerging research is revealing...
0 Comments 0 Shares 63 Views 0 Reviews